2008 Annual Meeting
Session: Reaction Engineering in Pharmaceuticals and Fine Chemicals
Presentations are solicited for reaction engineering in the development and scale-up of pharmaceutical and fine chemical processes. This work may include the integration of process analytical technology, modeling, and reactor design. Applications involving multiphase systems, mass transfer limited operations and novel reactor design on observed kinetic behavior is of particular interest to this session. Case studies that provide a better understanding of kinetics gained through process development are also encouraged to be submitted.
Chair
LaPorte, T. L., Bristol-Myers Squibb Company
Co-Chair
Hamedi, M., Merck and Co. Inc